People | 14 December 2022
AstraZeneca India appoints Dr. Sanjeev Panchal as Country President & MD
Sanjeev is currently the Country President for AstraZeneca Malaysia
Sanjeev is currently the Country President for AstraZeneca Malaysia
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
The company is in the process of appointing a new CFO.
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
She will provide strategic advice and scientific leadership to support clients in clinical development, registration strategy, submission, early post-approval strategy
He brings over 30 years of experience across various organizations such as Asian Paints PPG, Berger Paints, Tata Steel, among others
Reinforcing GLC’s commitment to sustainable processing in pharmaceutical chemistry
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
His experience covers a wide range of areas including advisory services in the field of accounting, taxation, corporate and commercial laws, and regulatory matters
Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
He has over 23 years' experience working in leading companies such as Omniactive Health Technologies, Johnson Matthey Chemicals, BASF, Godrej Agrovet Limited & Bharat Petroleum Corporation Limited.
Frazier led the company for 10 years as President and Chief Executive Officer, from 2011 through 2021.
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Subscribe To Our Newsletter & Stay Updated
